Anexon, Inc. — Form D
Anexon, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-10-19. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-10-19
- Form: D
- Accession: 0001140361-10-041614
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $3.0M
- Minimum investment: $83K
- Investors: 2
- Date of first sale: 2006-12-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-149305
Issuer
- Name: Anexon, Inc.
- CIK: 0001503090
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: C/O HEALTHCARE VENTURES, CAMBRIDGE, MA, 02142
- Phone: 617 252 4343
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Christopher K Mirabelli | Director | Cambridge, MA |
| Christopher K Mirabelli | Executive Officer | Cambridge, MA |
| Augustine K Lawlor | Director | Cambridge, MA |
| Steven K Van Nurden | Director | Rochester, MN |
| Douglas K Onsi | Director | Cambridge, MA |
| Douglas K Onsi | Executive Officer | Cambridge, MA |
Other filings by this issuer (2)
More